vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.

VIRTUS INVESTMENT PARTNERS, INC. is the larger business by last-quarter revenue ($199.5M vs $148.5M, roughly 1.3× OPKO HEALTH, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 3.6% vs -21.1%, a 24.6% gap on every dollar of revenue. On growth, VIRTUS INVESTMENT PARTNERS, INC. posted the faster year-over-year revenue change (-4.1% vs -19.2%). Over the past eight quarters, VIRTUS INVESTMENT PARTNERS, INC.'s revenue compounded faster (-5.7% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.

OPK vs VRTS — Head-to-Head

Bigger by revenue
VRTS
VRTS
1.3× larger
VRTS
$199.5M
$148.5M
OPK
Growing faster (revenue YoY)
VRTS
VRTS
+15.1% gap
VRTS
-4.1%
-19.2%
OPK
Higher net margin
VRTS
VRTS
24.6% more per $
VRTS
3.6%
-21.1%
OPK
Faster 2-yr revenue CAGR
VRTS
VRTS
Annualised
VRTS
-5.7%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPK
OPK
VRTS
VRTS
Revenue
$148.5M
$199.5M
Net Profit
$-31.3M
$7.1M
Gross Margin
43.1%
Operating Margin
-25.8%
7.7%
Net Margin
-21.1%
3.6%
Revenue YoY
-19.2%
-4.1%
Net Profit YoY
-322.8%
-78.1%
EPS (diluted)
$-0.04
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
VRTS
VRTS
Q1 26
$199.5M
Q4 25
$148.5M
$208.0M
Q3 25
$151.7M
$216.4M
Q2 25
$156.8M
$210.5M
Q1 25
$150.0M
$217.9M
Q4 24
$183.6M
$233.5M
Q3 24
$173.6M
$227.0M
Q2 24
$182.2M
$224.4M
Net Profit
OPK
OPK
VRTS
VRTS
Q1 26
$7.1M
Q4 25
$-31.3M
$33.9M
Q3 25
$21.6M
$31.3M
Q2 25
$-148.4M
$42.7M
Q1 25
$-67.6M
$28.1M
Q4 24
$14.0M
$39.5M
Q3 24
$24.9M
$49.1M
Q2 24
$-10.3M
$26.0M
Gross Margin
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
OPK
OPK
VRTS
VRTS
Q1 26
7.7%
Q4 25
-25.8%
19.1%
Q3 25
31.7%
21.7%
Q2 25
-38.3%
21.5%
Q1 25
-44.8%
16.8%
Q4 24
-18.0%
21.7%
Q3 24
8.2%
24.3%
Q2 24
-33.9%
19.7%
Net Margin
OPK
OPK
VRTS
VRTS
Q1 26
3.6%
Q4 25
-21.1%
16.3%
Q3 25
14.3%
14.5%
Q2 25
-94.7%
20.3%
Q1 25
-45.1%
12.9%
Q4 24
7.6%
16.9%
Q3 24
14.3%
21.6%
Q2 24
-5.7%
11.6%
EPS (diluted)
OPK
OPK
VRTS
VRTS
Q1 26
$1.05
Q4 25
$-0.04
$5.15
Q3 25
$0.03
$4.65
Q2 25
$-0.19
$6.12
Q1 25
$-0.10
$4.05
Q4 24
$0.02
$4.65
Q3 24
$0.03
$5.71
Q2 24
$-0.01
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
VRTS
VRTS
Cash + ST InvestmentsLiquidity on hand
$364.4M
$136.6M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$93.6B
Total Assets
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
VRTS
VRTS
Q1 26
$136.6M
Q4 25
$364.4M
Q3 25
$412.0M
Q2 25
$267.3M
Q1 25
$428.8M
Q4 24
$426.6M
Q3 24
$400.1M
Q2 24
$40.6M
Total Debt
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
$344.0M
$390.0M
Q3 25
$344.2M
$390.6M
Q2 25
$343.3M
$231.3M
Q1 25
$439.2M
$231.7M
Q4 24
$437.2M
$232.1M
Q3 24
$441.0M
$237.5M
Q2 24
$201.9M
$247.6M
Stockholders' Equity
OPK
OPK
VRTS
VRTS
Q1 26
$93.6B
Q4 25
$1.3B
$934.0M
Q3 25
$1.3B
$918.7M
Q2 25
$1.3B
$896.4M
Q1 25
$1.3B
$893.7M
Q4 24
$1.4B
$897.5M
Q3 24
$1.4B
$889.0M
Q2 24
$1.4B
$868.7M
Total Assets
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
$1.9B
$4.3B
Q3 25
$2.0B
$3.9B
Q2 25
$2.0B
$3.7B
Q1 25
$2.1B
$3.7B
Q4 24
$2.2B
$4.0B
Q3 24
$2.3B
$3.6B
Q2 24
$2.0B
$3.6B
Debt / Equity
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
0.27×
0.42×
Q3 25
0.26×
0.43×
Q2 25
0.26×
0.26×
Q1 25
0.33×
0.26×
Q4 24
0.32×
0.26×
Q3 24
0.31×
0.27×
Q2 24
0.14×
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
VRTS
VRTS
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
$-25.9M
$-67.2M
Q3 25
$-34.6M
$108.3M
Q2 25
$-83.4M
$75.8M
Q1 25
$-34.6M
$-3.8M
Q4 24
$-44.4M
$1.8M
Q3 24
$-77.1M
$69.1M
Q2 24
$-26.4M
$70.0M
Free Cash Flow
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
$-28.6M
$-74.1M
Q3 25
$-37.8M
$106.9M
Q2 25
$-86.7M
$74.2M
Q1 25
$-37.7M
$-6.8M
Q4 24
$-49.8M
$-3.8M
Q3 24
$-85.0M
$68.7M
Q2 24
$-33.7M
$68.6M
FCF Margin
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
-19.3%
-35.6%
Q3 25
-24.9%
49.4%
Q2 25
-55.3%
35.2%
Q1 25
-25.2%
-3.1%
Q4 24
-27.1%
-1.6%
Q3 24
-49.0%
30.3%
Q2 24
-18.5%
30.6%
Capex Intensity
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
1.8%
3.3%
Q3 25
2.1%
0.7%
Q2 25
2.1%
0.7%
Q1 25
2.1%
1.4%
Q4 24
2.9%
2.4%
Q3 24
4.6%
0.2%
Q2 24
4.0%
0.6%
Cash Conversion
OPK
OPK
VRTS
VRTS
Q1 26
Q4 25
-1.99×
Q3 25
-1.60×
3.45×
Q2 25
1.77×
Q1 25
-0.13×
Q4 24
-3.17×
0.04×
Q3 24
-3.10×
1.41×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

VRTS
VRTS

Investment management fees$169.1M85%
Administration and shareholder service fees$17.3M9%
Distribution and service fees$11.6M6%

Related Comparisons